Inflammation and Joint Tissue Interactions in OA: Implications for Potential Therapeutic Approaches
- PMID: 22745906
- PMCID: PMC3382955
- DOI: 10.1155/2012/741582
Inflammation and Joint Tissue Interactions in OA: Implications for Potential Therapeutic Approaches
Abstract
It is increasingly recognized that the pathogenesis of cartilage degradation in osteoarthritis (OA) is multifactorial and involves the interactions between cartilage and its surrounding tissues. These interactions regulate proinflammatory cytokine-mediated cartilage destruction, contributing to OA progression as well as cartilage repair. This review explores the pathogenesis of OA in the context of the multiple tissue types in the joint and discusses the implications of such complex tissue interaction in the development of anti-inflammatory therapeutics for the treatment of OA.
Similar articles
-
Local delivery of a carbohydrate analog for reducing arthritic inflammation and rebuilding cartilage.Biomaterials. 2016 Mar;83:93-101. doi: 10.1016/j.biomaterials.2015.12.029. Epub 2015 Dec 31. Biomaterials. 2016. PMID: 26773662 Free PMC article.
-
Anti-IL-20 monoclonal antibody inhibited inflammation and protected against cartilage destruction in murine models of osteoarthritis.PLoS One. 2017 Apr 20;12(4):e0175802. doi: 10.1371/journal.pone.0175802. eCollection 2017. PLoS One. 2017. PMID: 28426699 Free PMC article.
-
Kartogenin inhibits pain behavior, chondrocyte inflammation, and attenuates osteoarthritis progression in mice through induction of IL-10.Sci Rep. 2018 Sep 14;8(1):13832. doi: 10.1038/s41598-018-32206-7. Sci Rep. 2018. PMID: 30218055 Free PMC article.
-
Osteoarthritis: Trauma vs Disease.Adv Exp Med Biol. 2018;1059:63-83. doi: 10.1007/978-3-319-76735-2_3. Adv Exp Med Biol. 2018. PMID: 29736569 Review.
-
The role of cytokines in osteoarthritis pathophysiology.Biorheology. 2002;39(1-2):237-46. Biorheology. 2002. PMID: 12082286 Review.
Cited by
-
Utilising Discriminant Function Analysis (DFA) for Classifying Osteoarthritis (OA) Patients and Volunteers Based on Biomarker Concentration.Diagnostics (Basel). 2024 Aug 1;14(15):1660. doi: 10.3390/diagnostics14151660. Diagnostics (Basel). 2024. PMID: 39125536 Free PMC article.
-
Cutting-Edge Technologies for Inflamed Joints on Chip: How Close Are We?Front Immunol. 2022 Mar 10;13:802440. doi: 10.3389/fimmu.2022.802440. eCollection 2022. Front Immunol. 2022. PMID: 35359987 Free PMC article. Review.
-
Psychological Factors that Influence Decision-Making Regarding Trauma-Related Pain in Adolescents with Temporomandibular Disorder.Sci Rep. 2019 Dec 10;9(1):18728. doi: 10.1038/s41598-019-55274-9. Sci Rep. 2019. PMID: 31822745 Free PMC article.
-
The CREB1 inhibitor 666-15 maintains cartilage homeostasis and mitigates osteoarthritis progression.Bone Joint Res. 2024 Jan 2;13(1):4-18. doi: 10.1302/2046-3758.131.BJR-2023-0016.R2. Bone Joint Res. 2024. PMID: 38163445 Free PMC article.
-
Osteoarthritis Pain in Old Mice Aggravates Neuroinflammation and Frailty: The Positive Effect of Morphine Treatment.Biomedicines. 2022 Nov 8;10(11):2847. doi: 10.3390/biomedicines10112847. Biomedicines. 2022. PMID: 36359375 Free PMC article.
References
-
- Bitton R. The economic burden of osteoarthritis. The American Journal of Managed Care. 2009;15(8, supplement):S230–235. - PubMed
-
- Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nature Reviews Rheumatology. 2011;7(1):33–42. - PubMed
-
- Goldring SR, Goldring MB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clinical Orthopaedics and Related Research. 2004;(427, supplement):S27–S36. - PubMed
-
- Lawyer T, Wingerter S, Tucci M, Benghuzzi H. Cellular effects of catabolic inflammatory cytokines on chondrocytes. Biomedical Sciences Instrumentation. 2011;47:252–257. - PubMed
-
- Koenders MI, Marijnissen RJ, Devesa I, et al. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis. Arthritis and Rheumatism. 2011;63(8):2329–2339. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources